Procter & Gamble Pharmaceuticals

Actonel provides vertebral fracture risk reduction

Published in Hospital and Nursing Home Week, November 18th, 2004

Actonel (risedronate sodium tablets) reduces the risk of vertebral fracture up to 62% at 1 year in women with postmenopausal osteoporosis who are at risk for upper gastrointestinal (GI) side effects, according to new analyses presented at the American College of Rheumatology (ACR) annual meeting.

"These data are further evidence that Actonel provides fracture risk reduction across a broad range of postmenopausal women with osteoporosis, even those prone to experiencing GI side effects," said Karen Hansen, assistant professor of medicine, Rheumatology Division, University of Wisconsin Department of Medicine and chief of rheumatology, VA Hospital, Madison,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week

Source: Hospital and Nursing Home Week (2004-11-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry